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INTRODUCTION
Non-invasive ventilation (NIV) refers to the use of 
non-invasive techniques to deliver artificial respi-
ration to the lungs without the need for endotra-
cheal intubation. As NIV has proven beneficial in 
comparison to invasive mechanical ventilation, it 
has become the optimal modality for initial respi-
ratory support among children with respiratory 
distress. The first use of non-invasive techniques in 
the adult population was in the late 1980s.1
NIV is primarily used to avoid the need for 
endotracheal intubation in patients with early-stage 
acute respiratory failure and  post-extubation respi-
ratory failure. By definition, it is a  non-invasive 
technique, which can be applied on demand, 
causing less morbidity, and discomfort. It also 
allows preserving essential functions such as 
swallowing, feeding, speaking, and coughing. 
Heating and humidification of the inspired air are 
greatly respected. The primary goal of using NIV 
is to improve oxygenation by improving functional 
residual capacity and lung inflation in patients with 
an adequate respiratory drive.2
Techniques for NIV include continuous positive 
airway pressure (CPAP), bilevel positive airway 
pressure (BPAP), and more recently, a high-flow 
nasal cannula (HFNC). NIV improves the effective 
minute ventilation enhancing CO2 elimination by 
augmenting inspiration in patients with respiratory 
failure or impending respiratory failure without the 
use of an artificial airway.3
The majority of NIV in pediatric patients is 
utilized for the treatment of imminent respiratory 
failure associated with acute or chronic respiratory 
insufficiency secondary to pulmonary disease, 
neuromuscular disease, airway obstruction, infec-
tious processes, or post-extubation management 
or to avoid intubation or reintubation. NIV is not 
appropriate for patients with respiratory arrest, 
hemodynamic instability, multiple organ failure, 
recent upper airway or upper gastrointestinal 
surgery or bleeding, excessive sputum production 
or a diminished cough reflex or swallowing impair-
ment. As mentioned above, uncooperative or 
agitated patients are also not eligible for using NIV.4 
The advantages of NIV are widely reported in 
the scientific literature. It is much safer than inva-
sive mechanical ventilation. Compared to invasive 
ventilation, NIV lowers the risk of laryngeal swelling, 
post-extubation vocal cord dysfunction, barotrauma, 
and ventilator-associated pneumonia. One can 
communicate with the patient and does not require 
deep sedation.5 Complications of NIV include skin 
breakdown, gastric distention, interface discomfort, 
and nasal injury.6 On the other hand, the successful 
of NIV is determined by the selection of interfaces, 
good trained medical teams, and observation.
Department of Child Health, 
Faculty of Medicine, Udayana 
University, Bali, Indonesia
*Correspondence to:  
Vania Catleya Estina, Department 
of Child Health, Faculty of Medicine, 
Udayana University, Jl. PB Sudirman, 
Denpasar 80232, Bali, Indonesia 
vaniacatleya@gmail.com
Volume No.: 3
Issue: 2
First page No.: 106
E-ISSN.2549-2276
Doi: http://dx.doi.org/10.15562/bjoa.v3i2.165
ORIGINAL ARTICLE
ABSTRACT
Background: Non-invasive ventilation (NIV) has become an essential 
tool in the treatment of both acute and chronic respiratory failure in 
children. This study aimed to determine the efficacy of NIV usage in 
pediatric patients who were admitted to the Pediatric Intensive Care 
Unit (PICU) with respiratory failure.
Patients and Methods: This study is a retrospective, cross-sectional 
review. The data were collected from the medical record of PICU 
patients at our hospital from 2017 to 2018. Successful NIV was defined 
as patients who survived without intubation. Failure was defined as 
worsened patients and needed intubation for the rescue.
Results: The total subjects of this study was 78 patients. The most 
common indication for NIV was ARDS (78.1%), and CPAP was the 
most common frequently used (78.68%). The data shows that the NIV 
was commonly used after extubation (52.56%) than for the first-time 
rescue (47.44%). The success rate of NIV after extubation were 65.85% 
and 34.15% failed and shifted to mechanical ventilation. The duration 
of NIV usage was less than three days (73.77%). 
Conclusion: NIV is a useful tool for the treatment of respiratory failure 
in pediatrics. The use of post-extubation NIV may be a valuable tool to 
prevent reintubation. 
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This study aimed to determine the efficacy of 
NIV in pediatric patients who admitted to PICU 
with respiratory failure since the study of using 
NIV in Indonesia has not been widely studied.
PATIENTS AND METHODS
This research  was a descriptive, retrospective, 
cross-sectional study. The data were obtained from 
the medical record of patients who were applied 
NIV at the Pediatric Intensive Care Unit (PICU) 
of our hospital from January 2017 to December 
2018. The inclusion criteria were all patients aged 
one month to 18 years old. Subjects were excluded 
if the medical record data was not complete.  The 
research protocol was approved by the institutional 
review board. 
This research data included a primary character-
istic of the subject such as age, gender, nutritional 
status, diagnosis, the Pediatric Logistic Organ 
Dysfunction (PELOD) score, NIV mode, interface, 
duration of usage, and mortality incidence. Based 
on the formula used to see minimal sample size, we 
found the minimum sample size for this study was 
78 samples.7 The data was analyzed and presented 
descriptively using Microsoft Excel 2017 software 
tool. 
RESULTS
The most common age group used the NIV was 
below two years old. The male-to-female ratio 
was 1.1:1. The characteristics of the study subjects 
are presented in Table 1. In our hospital, we have 
introduced the HFNC since a few years ago. It is a 
relatively new, non-invasive ventilation therapy that 
seems to be well-tolerated in children. 
In this study, the most common conditions that 
needed NIV was post-extubation patients. There 
were, however, some patients required re-intuba-
tion after using the NIV. The most common mode 
of NIV was continuous positive airway pressure 
(CPAP). The oxygen fraction (FiO2) of 40% was 
often used for weaning in our hospital, but lower 
FiO2 values were also adjusted. 
DISCUSSION
In this study, we found that the most patients 
using NIV were well-nourished and malnourished. 
Schleder et  al.8 had concluded that nutritional 
status was not related to the time of permanence 
under invasive mechanical ventilation.
In this study, it showed that the majority of 
respondents were developing ARDS. The use of 
NIV for the treatment of ARDS remains contro-
versial. A previous study has demonstrated that 
approximately half of their patients were spared 
Table 1  Characteristics of the study 
subjects
Variable n = 78
Age, n (%)
0-2 years 66 (84.62)
3-5 years 7 (8.97)
6-11 years
12-18 years
5 (6.41)
0 (0) 
Sex, n (%)
Male 42 (53.85)
Female 36 (46.15)
Nutritional status, n (%)
Well-nourished 34 (43.59)
Malnourished 34 (43,59)
Severe malnutrition 6 (7.69)
Overweight 3 (3.85)
Obesity 1 (1.28)
The presence of ARDS, n (%)
Present 61 (78.21)
Absent 17 (21.79)
PELOD Score-2 1 day, n (%)
< 7 75 (96.15)
≥ 7 3 (3.85)
NIV modes, n (%)
CPAP 56 (71.79)
BiPAP 16 (20.51)
HFNC 6 (7.69)
The background of NIV application, 
n (%)
Rescue 37 (47.44)
Successful NIV 24 (64.86)
NIV failure 13 (35.13)
After extubation 41 (52.56)
Successful NIV 27 (65.85)
Reintubation after NIV usage 14 (34.14)
Interface, n (%)
Nasal mask 72 (92.31)
Facial mask 6 (7.69)
Full-facial mask 0 (0)
Nasal injury, (for nasal mask) n (%)
No 69 (95.83)
Yes 3 (4.16)
The duration of NIV, n (%)
≥ 72 hours 15 (19.23)
< 72 hours 63 (80.77)
Mortality
No 57 (73.08)
Yes 21 (26.92)
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from endotracheal intubation through the applica-
tion of NIV. The result was similar to the meta-anal-
ysis reported by Agarwal et al., that the severity of 
the disease was significantly higher in patients who 
received invasive ventilation only compared to NIV 
only, although there were no significant differences 
in the PICU’s length of stay. Patel et  al. evaluated 
ARDS patients submitted to NIV and drew atten-
tion to the importance of the NIV interface. They 
discussed their interesting findings focusing also 
on the ventilator settings and the current barriers to 
lung protective ventilation in ARDS patients during 
NIV.9
Table 3 showed that pneumonia (78.68%) was 
the most typical disease that required NIV. Asthma 
and aspiration pneumonia were the least. Our study 
was comparable to the previous study reported by 
Abadesso et al., in which the main diagnoses were 
bronchiolitis and pneumonia.10
In this study, the most frequent causes used NIV 
was neurology disease. According to previous jour-
nals and literature, the causes of respiratory failure 
in the children supported by NIV were chronic 
diseases-infection, neuromuscular diseases, renal 
transplantations-immunosuppression, leukemias, 
and respiratory infections.11 In the previous study, 
they found a few types of the underlying malig-
nancy (leukemia, lymphoma, solid tumor) that did 
not associate with NIV success or failure.12 Piastra 
et  al. had found that organ cancers were deter-
minant evident for NIV failure in critically care 
children.13
In this study, the PELOD-2 score was calculated 
on the first day the patients used NIV. The most 
frequent values of PELOD-2 score in this study was 
<7. Bernet et al.14 similarly did not find differences 
in PELOD between patients managed successfully 
and unsuccessfully on NIV, whereas Essouri et al. 
using PELOD and Paediatric Risk of Mortality 
(PRISM) scores have shown a correlation between 
these prognostic severity scores and prediction of 
NIV success.15
Septic shock affected NIV, distinctly (P = 0.027) 
and the failure group showed increased rate. 
Steroid use was stated for the success and failure 
group (seven success and twelve failures in chil-
dren who applied NIV). Statistically, a significant 
difference was found in both group (P = 0.017), but 
not inotropic and granulocyte colony-stimulating 
factor a use, but not inotropic and granulocyte 
colony-stimulating factor use.
Bi-level positive airway pressure (BiPAP) 
devices provide two levels of positive airway pres-
sure during the respiratory cycle. A higher level 
of pressure is provided during inspiration, and a 
lower level of pressure is provided during expira-
tion. In this study, CPAP mode was the most used. 
This is similar to data on heterogeneous modes of 
NIV modalities in the PICU described in separate 
studies conducted by Yaman et  al., that reported 
NIV support with BiPAP mode was given to 57.5% 
(92 episodes) of the patients, while the remaining 
42.5% (68 episodes) received CPAP support, and 
there was none with high-flow nasal cannula.16 
Manley et al. compared treatment failure in infants 
within three days of extubation comparing the 
use of HFNC with CPAP. In that study, 34.2% of 
the nasal cannula infants experienced treatment 
failure, whereas 25.8% of the CPAP group demon-
strated failure. Of the failures, 50% were success-
fully treated with CPAP without re-intubation. 
Based on their predetermined criteria, this led to 
Table 2  Characteristics of subjects treated due to ARDS
Variable n = 61
NIV, n (%)
CPAP 48 (78.68)
BiPAP 13 (21.31)
HFNC 0 (0)
The Goal of using NIV, n (%)
Rescue 37 (47.44)
Successful NIV 24 (64.86)
NIV failure 13 (35.13)
After extubation 35 (57.37)
Successful NIV 
Re-Intubation after using NIV
25 (71.42)
10 (28.57)
The Duration of NIV, n (%)
≥ 72 hours 16 (26.22)
< 72 hours 45 (73.77)
Mortality
No 40 (65.57)
Yes 21 (34.42)
Table 3  The clinical diagnosis of pediatric patients who used NIV
Variable n = 78
Respiratory diagnoses, n (%)
Pneumonia 48 (78.68)
Bronchiolitis 8 (13.11)
Asthma 3 (4.91)
Aspiration pneumonia 2 (3.27)
Non-Respiratory diagnoses, n (%)
Neurology 6 (35.29)
Postoperative 5 (29.41)
Gastrohepatoenterology 2 (11.76)
Hematology 2 (11.76)
Immunology 2 (11.76)
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a conclusion that the use and efficacy of HFNC 
was not inferior and was therefore similar to that 
of CPAP as a form of respiratory support for very 
preterm infants following extubation.16
In this study, although there are several subjects 
that demonstrated failure from the NIV, the number 
of successes from using the NIV is also significant. 
This is certainly in accordance the to another report 
that studied the early use of NIV on the PICU may 
serve as a first line interventional tool to prevent 
intubation.17
Limitations associated with the successful 
application and use of CPAP and NIV can be 
attributed to the patient interfaces, the delivery 
devices, and the available technology. Interfaces 
include a nasal cannula, nasal pillows, nasal masks, 
oronasal masks, total face masks, and extended 
nasal cannula or nasal tubes positioned in the nasal 
pharyngeal airway. The primary patient interfaces 
used in small infants are nasal cannula and nasal 
masks. Both nasal cannula and nasal masks are 
associated with system leaks, which may necessi-
tate the use of a chin strap to maximize positive 
pressure delivery.18 On the characteristic of inter-
face in this study, the most frequently used was 
‘nasal mask’.
In the event of nasal injury, only a few who had 
a nasal injury after using NIV. Some studies show 
that the prolonged time of use of nasal prongs 
increases the risk of nasal injury. However, in that 
study, terse times were noted before the occurrence 
of nasal injury in 60% of the patients analyzed. The 
patients developed injuries within an average of 
18 hours of use, enabling us to infer that care and 
constant vigilance significantly affect the onset of 
injuries and that evaluations of the improvement 
of the quality of care for infants should include 
nasal injury triggered by the use of nasal cannula 
for NIV as an indicator. Another factor possibly 
associated with the onset of nasal injuries is linked 
to the manufacturing brand of the device, which, 
in turn, is related to the quality of the material and 
the nasal cannula design (for example, the distance 
between the nasal catheter insertion and the cath-
eter’s length). There were no statistically significant 
differences between the children with nasal injuries 
and those without, although chemical and physical 
structures of the materials used in the nasal cannula 
have not been analyzed.19
In this study, there was the commonest used NIV 
for more than three days. On the previous study, 
NIV support median duration was 48 hours (range: 
2-448), and in the successful group (no reintuba-
tion), the average NIV duration was 48 hours while 
this was 20 hours in the unsuccessful group (with 
re-intubation).20 Besides that, in this study, there 
was 26.92% death after used NIV.
 
 
 
 
 
 
 
 
 
 
 
 
  The  limitation  of  this  study  is  related  to  its 
limited  number  of  subjects.  Also,  there  are  no 
description of the NIV setting, patients’ vital signs, 
and  ventilator-free  day  outcomes.  A  further  study 
is needed to describe the utilization of NIV in chil- 
dren, determinate the efficacy of NIV, and describe
its safety profile in PICU patients.
CONCLUSION
NIV is a useful tool for the treatment of respiratory 
failure  in  pediatrics.  The  use  of  post-extubation
NIV may be a valuable tool to prevent reintubation.
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